Grown Rogue International (GRUSF) Current Assets (2011 - 2026)
Grown Rogue International's (GRUSF) quarterly Current Assets came in at $24.9 million in Q1 2026, down 8.41% year-on-year from $27.1 million in Q1 2025, and up 12.07% quarter-over-quarter from $22.2 million in Q4 2025.
Grown Rogue International (GRUSF) Current Assets (2011 - 2026) Analysis & Trends
Grown Rogue International's Current Assets history runs 16 years deep, the most recent figure standing at $24.9 million for Q1 2026.
- On a quarterly basis, Current Assets fell 8.41% year-over-year to $24.9 million in Q1 2026; TTM through Mar 2026 was $24.9 million, a 8.41% decrease from a year earlier, with the FY2025 full-year figure at $22.2 million, up 69.1% from the prior year.
- Current Assets advanced to $24.9 million in Q1 2026 per GRUSF's latest filing, from $22.2 million in the prior quarter.
- Across five years, Current Assets topped out at $31815.8 billion in Q3 2025 and bottomed at $7.9 million in Q4 2022.
- The 5-year median for Current Assets is $15.7 million (2023), against an average of $2272.6 billion.
- Across the five-year window, Current Assets jumped 228661551.88% in 2025 and dropped 8.41% in 2026, its largest moves.
- Year by year, Current Assets stood at $7.9 million in 2022, then surged by 44.98% to $11.5 million in 2023, then grew by 14.37% to $13.1 million in 2024, then surged by 69.1% to $22.2 million in 2025, then increased by 12.07% to $24.9 million in 2026.
- Per Business Quant, the three latest GRUSF Current Assets figures stand at $24.9 million (Q1 2026), $22.2 million (Q4 2025), and $31815.8 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 24.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.86 Mn |
| Dec 31, 2025 | 22.18 Mn |
| Sep 30, 2025 | 31,815.77 Bn |
| Jun 30, 2025 | 26.78 Mn |
| Mar 31, 2025 | 27.14 Mn |
| Dec 31, 2024 | 13.12 Mn |
| Sep 30, 2024 | 13.91 Mn |
| Jun 30, 2024 | 13.12 Mn |
| Mar 31, 2024 | 20.04 Mn |
| Dec 31, 2023 | 11.47 Mn |
| Oct 31, 2023 | 17.42 Mn |
| Apr 30, 2023 | 10.66 Mn |
| Jan 31, 2023 | 10.18 Mn |
| Oct 31, 2022 | 7.91 Mn |
| Oct 31, 2021 | 1,453.00 |
| Apr 30, 2021 | 3.63 Mn |
| Jan 31, 2021 | 2.71 Mn |
| Oct 31, 2020 | 74,961.00 |
| Jul 31, 2020 | 1.91 Mn |
| Apr 30, 2020 | 1.61 Mn |